Virus-inactivating composition

A virus inactivating composition using weathered granite eluates with inorganic acids effectively targets and inactivates influenza and SARS-CoV2 viruses in the oral cavity and on skin, addressing current disinfectant inefficiencies with minimal irritation and toxicity.

JP2024157061AInactive Publication Date: 2024-11-07SHIMANISHI KAKEN
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2021134418
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2021-07-13
Publication Date
2024-11-07
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current disinfectants are ineffective in inactivating influenza and novel coronavirus (SARS-CoV2) viruses, particularly in the oral and nasal cavities, and do not address contact infections without causing skin irritation or toxicity.

Method used

A virus inactivating composition derived from weathered granite containing vermiculite, eluted with inorganic acids, generates metal and non-metal salts that form hydroxyl radicals for strong oxidizing power, diluted to specific ratios for safe use as an oral disinfectant or skin sanitizer.

Benefits of technology

The composition effectively inactivates viruses in the oral cavity and on skin surfaces with minimal irritation or toxicity, maintaining immune function and preventing viral adherence and multiplication.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024157061000001_ABST
    Figure 2024157061000001_ABST
Patent Text Reader

Abstract

To provide a virus-inactivating composition comprising an appropriately diluted aqueous solution of an acid eluate containing a metal salt as a main component for inactivating the new coronavirus and influenza virus.SOLUTION: The problem is solved by a virus-inactivating composition, characterized by consisting of a diluted aqueous solution of an eluate containing, as main components, a large number of metal salts obtained by eluting igneous rock represented by granite, contact metamorphic rock, and / or weathered rocks thereof with inorganic acid and / or organic acid.SELECTED DRAWING: Figure 2
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a virus inactivating composition that inactivates the novel coronavirus (SARS-CoV2) and influenza viruses that cause nasal, oral, and upper respiratory tract infections, and relates to a virus inactivating composition suitable for use in hygiene products used for oral disinfection and body washing. [Background technology]

[0002] The history of humans and viruses began at the birth of mankind, and has caused countless pandemics throughout history, bringing misfortune to humanity. In recent years, the infection mechanisms of some of the viruses that cause these pandemics have gradually come to light.

[0003] For example, the measles virus, which causes infectious diseases, has various routes of infection, including droplet nuclei infection (airborne infection), droplet infection, and contact infection, and is highly contagious. Once inside the human body, the measles virus grows mainly in the lymphatic tissue throughout the body, which is responsible for immunity, causing a strong immune suppression state, which leads to the aggravation of infections caused by other bacteria. Poliovirus also infects motor nerve cells in the spinal cord, brain stem, and cerebral cortex, causing paralysis of the lower limbs. The AIDS virus (HIV) infects receptors in immune cells, causing immunodeficiency. Herpes virus (HSV) is caused by close contact with an individual who is actively releasing the virus, and after infection, it lies dormant in nerve ganglia, from which it periodically emerges and causes symptoms.

[0004] On the other hand, the infection routes of the novel coronavirus (SARS-CoV2) and influenza viruses are said to be droplet and contact infections. In particular, part of the novel coronavirus (SARS-CoV2) that enters through the nasal cavity or oral cavity attaches to the oral mucosa in the nasal cavity or oral cavity, and from there enters the trachea and bronchi and reaches the alveoli. The spike protein of influenza viruses and novel coronavirus (SARS-CoV2) acts as a key, attaching to a keyhole called a receptor on the cell surface and infecting the virus. Since the receptors are located in the cells of the nasal cavity, oral cavity, and airway epithelium, it is said that respiratory epithelial cells are infected first. In addition, there are reports that the novel coronavirus directly infects cells of the gums, inside the cheeks, and tongue, and proliferates in the mouth.

[0005] Patent Document 1 discloses a bactericidal disinfectant made of a mineral-containing solution derived from mica-based minerals. The mineral-containing solution exerts a bactericidal and disinfecting effect by oxidizing action caused by the generation of OH radicals, and describes its bactericidal and disinfecting effect against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella enterica, Salmonella typhi, and human immunodeficiency virus. [Prior art documents]

[0006] [Patent Document 1] Japanese Patent Application Publication No. 7-238004 Summary of the Invention [Problem to be solved by the invention]

[0007] As mentioned above, unlike the measles virus, poliovirus, AIDS virus, and herpes virus, the novel coronavirus and influenza virus first infect and multiply in respiratory epithelial cells or directly in the oral cavity, so there is a strong need to inactivate the viruses in the oral cavity.

[0008] Although the prior art documents describe the inactivation effect against measles virus, human immunodeficiency virus, herpes virus, and polio virus, there is no mention of the influenza virus or the new coronavirus.

[0009] As mentioned above, each type of virus has its own unique properties, and the inactivating agents used to combat these viruses also differ depending on the type of virus. The prior art documents do not suggest inactivation of influenza viruses or the new coronavirus.

[0010] In addition, even if the measles virus, polio virus, AIDS virus, and herpes virus attach to the body and enter the human body through the nasal or oral cavity, once infection has begun, germicides and disinfectants do not come into direct contact with the viruses, and there is no description of a prescription for inactivating the invading viruses.

[0011] Currently, the most commonly used germicides include alcohols such as ethyl alcohol and isopropyl alcohol, phenols such as phenol, cresol, and chlorhexidine, halogens such as chlorine gas, sodium hypochlorite, iodine and potassium iodine solutions, and tincture of iodine. Further, alkylating agents such as formaldehyde and glutaraldehyde, oxidizing agents such as hydrogen peroxide and potassium permanganate, and surfactants such as soap are also used.

[0012] Among these, ethyl alcohol, sodium hypochlorite, povidone-iodine, glutaraldehyde, and potassium permanganate are used for antiviral purposes, and povidone-iodine and hydrogen peroxide are effective for disinfecting the oral cavity and pharynx.

[0013] Of these, povidone-iodine can be used in the oral cavity and pharynx, and its 7% solution and diluted solutions are reported to be effective in inactivating the new coronavirus. However, one gargle contains 14 to 28 mg of iodine. The amount of iodine absorbed into the body is unclear, but the upper limit of iodine that can be administered in one day is set at 3 mg, making it difficult to gargle multiple times a day. It is believed that exceeding this standard for a long period of time can cause abnormalities in the thyroid gland.

[0014] As described above, currently no disinfectant has been found that can act directly on the oral cavity, nasal cavity, pharynx, and larynx to inactivate the new coronavirus that proliferates in the oral cavity, which serves as a kind of incubator, and attaches to and proliferates there.

[0015] On the other hand, there is a need to address contact infection, which is one of the routes of infection. Ethyl alcohol and hypochlorous acid liquid are generally used to disinfect viruses, sputum, and feces attached to the body, as well as parts that people touch. However, as the frequency of use increases, the sebum components on the skin also decrease at the same time, causing rough skin. No liquid composition has been found that solves this problem, does not have a negative effect on the skin, and is effective in inactivating influenza viruses and the new coronavirus.

[0016] The present invention aims to provide a virus inactivation composition consisting of an appropriately diluted aqueous solution of an acid eluate containing a metal salt as a main component in order to inactivate the new coronavirus and influenza virus, and further to provide an oral disinfectant and hygiene product based on an appropriate formulation for inactivating viruses that have come into contact with or entered the human body via the nasal or oral cavity. [Means for solving the problem]

[0017] The present invention relates to rocks formed when magma cools and solidifies, and their parent rocks are granite, peridotite, gabbro, diorite, komatiite, basalt, andesite, rhyolite, and granite porphyry. By dissolving these weathered bodies and powders in inorganic or organic acids, various myrrh components are eluted, and by diluting the resulting mineral solution with drinking water to a specific range, it was discovered that the mineral solution inactivates the new coronavirus (SARS-CoV2) and influenza virus, which led to the invention.

[0018] Among the above mineral solutions, a mineral solution obtained by using weathered eroded granite containing vermiculite, a mica-based mineral, as the raw material and eluting it with an inorganic acid having a high elution rate is preferred because it does not contain arsenic, lead, mercury, chromium, or cadmium, and contains a variety of metal salts including iron, magnesium, potassium, manganese, calcium, aluminum, zinc, silicon, sodium, copper, phosphorus, titanium, nickel, cobalt, molybdenum, lithium, vanadium, tungsten, rubidium, germanium, selenium, and barium as mineral components, as well as phosphorus as a non-metallic salt.

[0019] Inorganic acids that can be used include sulfuric acid and hydrochloric acid, and organic acids include acetic acid, citric acid, L-tartaric acid, succinic acid, lactic acid, etc., but inorganic acids that relatively easily dissolve mineral components are preferred, and sulfuric acid is most preferred because of its bactericidal and antiviral effects.

[0020] The mechanism by which the virus inactivating composition of the present invention inactivates viruses is a complex interaction between various metal components and acids, and has not been fully elucidated, nor is it an established inactivation theory. However, it is believed that various transition metals and nonmetals produce metal salts and nonmetal salts with acids, and various metals form complex salts, which results in the production of hydroxyl radicals·OH, which have strong oxidizing power. Hydroxyl radicals·OH have an unstable electronic state as oxygen, and therefore have a strong ability to pull out electrons from surrounding substances, i.e., strong oxidizing power, and are therefore thought to act directly on viruses. On the other hand, it is believed that by taking the virus inactivating composition into the body, hydroxyl radicals·OH are produced in the process of various reactions in the body, and their strong oxidizing power acts as a disinfectant against viruses and maintains and improves immune function.

[0021] The eluate, which is made from weathered corroded granite and contains various metal salts and nonmetal salts eluted with sulfuric acid, has a strong acidity of 0.1 to 2.0, but does not cause chemical burns to the skin or cell epithelium because it forms complexes with a large number of various metal components. However, while this eluate has a strong virus inactivation effect, the strong acidity acts on the taste sensors in the oral cavity and causes strong irritation, so the eluate must be diluted with drinking water to be used as an oral disinfectant. In addition, when inactivating viruses that are attached to the skin of the body or objects that the body comes into contact with, the eluate has a strong inactivating effect, but its strong oxidizing power causes discoloration and deterioration of the objects, so the eluate must be diluted with drinking water.

[0022] That is, in the present invention, when a virus inactivating composition that inactivates the novel coronavirus (SARS-CoV2) is used as an oral disinfectant targeting the novel coronavirus, the virus inactivating composition is diluted 80 to 800 times. This diluted virus inactivating composition is taken into the oral cavity, held there for at least 5 seconds and / or gargled, and then expelled or swallowed within or before 300 seconds, thereby inactivating the novel coronavirus (SARS-CoV2) attached to the oral mucosa and proliferating in the oral cavity.

[0023] When used as an oral disinfectant targeting influenza viruses, the virus inactivating composition is diluted 800 to 5000 times. This diluted virus inactivating composition is taken into the oral cavity, held there for at least 1 second and / or gargled, and then expelled or swallowed within or before 20 seconds, thereby inactivating influenza viruses attached to the oral mucosa.

[0024] When targeting the novel coronavirus attached to the body and / or parts of the body, or medical equipment used for treatment, the virus inactivation composition is diluted 50 to 4,000 times, and this diluted virus inactivation composition is impregnated and attached to nonwoven, woven, or knitted fabrics and used for washing the body and / or for disinfecting objects to which droplets may adhere.Furthermore, the problem is solved by the hygiene products and disinfectants that inactivate the novel coronavirus (SARS-CoV2) attached to the body or medical equipment by immersing the body part or medical equipment used for treatment in the composition, or by spraying or spraying the body part or medical equipment used for treatment in the composition. Effect of the Invention

[0025] The virus inactivation composition of the present invention is excellent at inactivating the new coronavirus (SARS-CoV2) and influenza virus, is non-toxic to human cells, and is safe. The oral disinfectant of the present invention, diluted at an appropriate ratio for each virus, can inactivate viruses that have attached and proliferated in the oral cavity, and since the oral disinfectant that has been left in the oral cavity can be swallowed as is, it is also possible to inactivate some of the viruses that have attached and proliferated in the pharynx and epiglottis. In addition, the sanitary products and disinfectants for the new coronavirus of the present invention can inactivate and remove the new coronavirus that has attached to the epidermis of the body, such as hands and fingers, and viruses that have attached to medical equipment can also be inactivated by immersing, spraying, or spraying the disinfectant. [Brief description of the drawings]

[0026] [Figure 1] Dilution ratio and pH value of elution solution [Diagram 2] Virus reduction rate of each sample compared to the control [Diagram 3] The viral infectivity of the present invention when the viral infectivity of the control is set to 100 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0027] Figure 1 shows the pH value of the elution solution measured for each dilution ratio, and the values ​​plotted on a logarithmic graph in order to find the appropriate dilution ratio of the elution solution suitable for the new coronavirus (SARS-CoV2) and influenza viruses. As shown in Figure 1, diluted aqueous solutions with a dilution ratio of 50 or less have a pH < 1.0, which is stronger than the sourness of lemon juice, which has a pH of around 2.5, and feels more sour and stimulating than lemon juice. On the other hand, at a dilution ratio of 4000, the pH is ≒ 3, and the diluted aqueous solution is less sour than lemon juice.

[0028] Five subjects took diluted solutions of different dilution ratios into their mouths, and the sourness and level of irritation felt by each subject was recorded. The diluted solutions were then left in the mouths and the subjects were checked at regular intervals to see if they could tolerate the acidic taste and level of irritation.

[0029] When diluted aqueous solutions of 50, 80, 150, 400, 800, 1600, and 3200 times were taken into the oral cavity and left there, the tolerable time varied depending on the dilution ratio, with the optimal time being 1 to 300 seconds.

[0030] As a result, when used as an oral disinfectant, the dilution ratio must be 80 or more, due to the sour taste and irritation felt when taken into the mouth, and the retention time for an 80-fold diluted solution was up to 120 seconds. When the dilution ratio was 800, the retention time in the mouth was 300 seconds or less, and some subjects experienced slight sensory abnormalities if the dilution ratio was 800 or more.

[0031] From the above, when targeting the new coronavirus, a diluted aqueous solution with a dilution ratio of less than 80 times kills the virus in a short time with a high probability, but the acidity and irritation felt in the oral cavity are strong, and it is painful to keep the diluted aqueous solution in the oral cavity, so it cannot be used practically. In addition, a diluted aqueous solution with a dilution ratio of more than 800 times reduces the discomfort of keeping it in the oral cavity, but on the other hand, the virus killing rate decreases and the inactivation effect decreases. Therefore, the dilution ratio of the elution solution suitable as an oral disinfectant for the new coronavirus is 80 to 800 times, and preferably the dilution ratio is 120 to 500 times. Furthermore, it was found that the appropriate time to keep it in the oral cavity is 5 to 300 seconds.

[0032] In the case of the novel coronavirus, the dilution ratio should be adjusted depending on the purpose of use. For example, for infected individuals, a diluted aqueous solution with a dilution ratio of 80 times or more and close to 80 times is preferable, whereas for non-infected individuals for the purpose of preventing infection, a dilution ratio of no more than 800 times and close to 800 times should be selected.

[0033] When targeting influenza virus, an 800-fold diluted aqueous solution can kill the virus in 1 second. When using oral disinfectants for daily infection prevention, even a 3000-fold diluted aqueous solution is effective, as it causes almost no sourness or irritation. Therefore, the appropriate dilution ratio of the eluate as an oral disinfectant for influenza virus is 800 to 5000 times, and preferably 1500 to 3000 times.

[0034] On the other hand, when the target is disinfection of viruses, sputum, and feces attached to the body, or even parts that people touch, there is no need to consider acidity or irritation, so the dilution ratio can be set in a wider range than oral disinfectants, and an aqueous solution diluted 50 to 4000 times can be used. If the dilution is less than 50 times, the closer it is to the elution solution, the more irritating it may be to the skin, even if only slightly, due to the oxidation effect, and it may cause discoloration of nonwoven fabrics or towels that carry the diluted aqueous solution, making it difficult to apply. Also, if the dilution exceeds 5000 times, the inactivation effect against viruses decreases, which is not preferable.

[0035] The drinking water used in the dilution solution is not particularly limited as long as it is drinkable water, but in addition to tap water, spring water, and the like, distilled water, physiological saline, or when the taste and irritation of the diluted acid is strong, fruit juice or a sweetener may be added to mitigate this. EXAMPLES

[0036] (Virus inactivation evaluation) Weathered eroded granite containing vermiculite, a mica-based mineral, was used as the raw material, and the raw material and inorganic acid solution were added in a weight ratio of 4:3-4, heated to 80 degrees and stirred for several hours, and then filtered to produce an eluate containing sulfates, oxides, and complex salts of metals and nonmetals. The inorganic acid used was 25% and the sulfuric acid was 25%. The obtained eluate was diluted 150 times with drinking water, and the obtained oral disinfectant for inactivating the new coronavirus of the present invention was used as a test subject to evaluate its virus inactivation performance by the following method.

[0037] Control: Virus solution with 0 min reaction time Reference: Tap water Virus: Novel human coronavirus (SARS-CoV2 WK-521) Viral titer (undiluted): 3.6 x 10 4 TCID 50 / mL Cell: Vero cell Test overview: The sample was mixed with a virus solution, and after the reaction time, the virus solution was collected and used to infect cells to measure the amount of infectious virus.

[0038] Virus preparation: 3.0 × 10 Vero cells 5 After adjusting the cell / mL, 10 mL was added to 75 cm 3 37 0 C. After 1 day of incubation in a 5% CO2 incubator, 5 ~10 6 TCID 50 100 μL of SARS-CoV2 was inoculated and cultured for 3 days, and the TCID 50 The virus titer was measured according to the method. Prepare cells: 1.0 x 10 Vero cells 5 After adjusting the concentration to cells / mL, the cells were seeded in 100 μwells of a 96-well plate and cultured for one day in an incubator at 37°C with a CO2 concentration of 5%. Preparation of test specimen: 975 μL of test specimen was seeded onto a 247-well plate.

[0039] Reaction of the virus with the specimen: 25 μL of the virus solution was mixed with the specimen and allowed to react. The reaction time was 1 minute, and then 100 μL of the virus mixture was added to 900 μL of serum-free DMEM medium to stop the reaction.

[0040] Addition to Vero cells and incubation: The diluted solution in the test sample preparation was inoculated into the cells prepared in the virus preparation step, 100μL / well, 3 wells per test sample and reaction time. After incubation for 1 day in an incubator at 37°C with a CO2 concentration of 5%, the amount of infectious virus was measured and the antiviral activity of each test sample was evaluated.

[0041] The results are shown in Table 1 and shown as a bar graph in Figure 3. That is, when the virus infectivity of the control was set to 100, the virus infectivity in each sample at a reaction time of 0 minutes was confirmed to have decreased to 0.6% after 1 minute.

[0042] The virus reduction rate of each sample compared to the control is shown in Table 2, and a bar graph is shown in Figure 2. That is, the oral disinfectant for inactivating the new coronavirus of the present invention was confirmed to reduce the virus infectivity by 99.4% after 1 minute compared to the reaction time of 0 minutes.

[0043] [Table 1]

[0044] [Table 2] EXAMPLES

[0045] The same eluate as in Example 1 was diluted 2000-fold with drinking water, and the resulting oral disinfectant for inactivating influenza viruses of the present invention was used as a test subject to evaluate its virus inactivation performance by the following method.

[0046] Control: Virus solution with 0 min reaction time Virus: Influenza virus H1N1 A / PR / 8·34 Cells: MDCK cells (canine kidney cells) Test method: After dispensing 1.08 mL of the influenza virus inactivating oral disinfectant into a tube, dilute it with phosphate buffer (PBS) at 5-10 x 10 5 0.12 mL of influenza virus solution adjusted to pfu / mL was mixed and stirred to prepare the test solution.

[0047] The test solution was left to stand at room temperature and reacted. Immediately after, and every 1 and 5 minutes, the solution was collected from the test solution and mixed with 1.08 mL of Dulbecco's modified Eagle medium containing 0.2% bovine serum. Dilution with 0.2% FBS-DMEM medium was repeated several times to create a 10-fold serial dilution series, and 1 mL / well of the 10-fold serial dilution solution was dropped onto the host cells prepared in advance and infected for 1 hour at 37°C and 5% CO2. After virus infection, the cell supernatant was replaced with 0.8% oxoid agar solution, and the cells were cultured for 2 days at 37°C and 5% CO2, fixed and stained with 5% glutaraldehyde solution, and the virus infection titer was measured based on the measurement data of the number of plaques formed.

[0048] As a result, it was confirmed that the oral disinfectant for influenza viruses of the present invention, which was prepared by diluting the eluate 2000 times, inactivated 99.988% or more of the viruses immediately after application. The results are shown in Table 3.

[0049] [Table 3] EXAMPLES

[0050] (Cytotoxicity test) A cytotoxicity evaluation was conducted to confirm that the oral disinfectant for inactivating the new coronavirus of the invention used in Example 1 is not toxic to cells.

[0051] The "reaction between virus and specimen" test carried out in Example 1 was carried out using 25 μL of serum-free DMEM instead of the virus solution, and the solution that came into contact with the specimen was adjusted to evaluate cytotoxicity. The enzyme activity that reduces the MTT dye to formazan dye in the cells is optically measured. As a result, if the number of cells decreases due to death or other reasons, the amount of luminescence will decrease.

[0052] 1.0 × 10 Vero cells 5 After adjusting the concentration to cella / mL, the cells were seeded onto a 96-well plate and cultured for one day in an incubator at 37°C with a CO2 concentration of 5%. 975μL of each specimen was seeded in a 24-well plate. 25μL of serum-free DMEM was mixed with the specimen and reacted for 1 minute. The reaction was stopped, and the diluted solution was seeded on Vero cells cultured in each well at 100μL / well, 3 wells per specimen, and cultured at 37°C and 5% CO2 for 1 day. 10μL of MTT solution was added to each well, and the color reaction was carried out at 37°C and 5% CO2 for 2 hours. 100μL of solubilization solution was added to each well, and the absorbance value at 595nm was measured using a microplate reader.

[0053] The results are shown in Table 4. From Table 4, it was confirmed that the oral disinfectant for the new coronavirus of the present invention is not toxic to cells that come into contact with the solution.

[0054] [Table 4] EXAMPLES

[0055] Five subjects experienced the appropriate dilution ratio of the COVID-19 oral disinfectant, and the sourness and irritation felt when it was taken into the mouth and left there. The sourness was divided into five ranks and each person rated it, with the median value shown in Table 5. Irritation was divided into four ranks and a judgment was made as to whether it was acceptable or not for each time it was left there. The results are shown in Table 6 according to the number of people out of the five who judged it to be unacceptable: × -> 4 or more people unacceptable, ▲ -> 2 to 3 people unacceptable, △ -> 1 person unacceptable, ○ -> all acceptable.

[0056] [Table 5]

[0057] [Table 6] EXAMPLES

[0058] A certain amount of disinfectant that inactivates the new coronavirus (SARS-CoV2) was applied to polypropylene nonwoven fabric to make wet tissues. The resulting hygiene products were ideal as disposable items for disinfecting the new coronavirus.

Claims

1. A virus inactivating composition that inactivates the novel coronavirus (SARS-CoV2) and influenza viruses, comprising a diluted aqueous solution of an eluate containing, as main components, a large number of metal salts eluted from igneous rock, typically granite, contact metamorphic rock, and / or weathered rocks thereof with inorganic acid and / or organic acid.

2. 2. The virus inactivating composition according to claim 1, characterized in that the raw material is weathered granite, the eluate is sulfuric acid, the metals constituting the metal salt contain six or more metals selected from iron, magnesium, aluminum, potassium, zinc, barium, copper, nickel, titanium, calcium, manganese, sodium, cobalt, lithium, silicon, molybdenum, vanadium, tungsten, rubidium, germanium and selenium, or all of them, and further contain phosphorus as a non-metallic component.

3. The virus inactivating composition is diluted at a dilution ratio of 80 to 800 times, and is held in the oral cavity for at least 5 seconds and / or gargled, and then expelled or swallowed within or before 300 seconds, thereby inactivating the novel coronavirus (SARS-CoV2) that has adhered to the oral mucosa and proliferated in the oral cavity.

4. The oral disinfectant for influenza viruses according to any one of claims 1 and 2, characterized in that the virus inactivating composition is diluted at a dilution ratio of 800 to 4000 times, and inactivates influenza viruses that are excreted or swallowed and attached to the oral mucosa within or before 20 seconds after being held in the oral cavity for at least 1 second and / or gargled.

5. The disinfectant according to any one of claims 1 and 2, characterized in that the virus inactivating composition is diluted at a dilution ratio of 50 to 4,000 times, impregnated and attached to a nonwoven fabric, woven fabric, or knitted fabric, and used for washing the body and / or for disinfecting objects on which droplets may adhere, and further, is immersed in, or sprayed on, a part of the body or a medical device used in treatment, thereby inactivating the novel coronavirus (SARS-CoV2) attached to the body or medical device.

6. A sanitary product to which the disinfectant according to claim 5 is applied as a virus inactivating agent, the sanitary product being a wet tissue, a wet hand towel, a wet towel, or a disinfectant.

Citation Information

Patent Citations

  • Microbicidal sterilizer

    JP1995238004A